HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Neumann, T. Articles by Pitschner, H.-F. PubMed Articles by Neumann, T. Articles by Pitschner, H.-F. Related Collections Related Article

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Circumferential Pulmonary Vein Isolation With the Cryoballoon Technique

Results From a Prospective 3-Center Study

Thomas Neumann, MD^_*,_*, Jürgen Vogt, MD, Burghard Schumacher, MD, Anja Dorszewski, MD, Malte Kuniss, MD^_*, Hans Neuser, MD, Klaus Kurzidim, MD^_*, Alexander Berkowitsch, PhD^_*, Marcus Koller, MD, Johannes Heintze, MD, Ursula Scholz, MD, Ulrike Wetzel, MD, Michael A.E. Schneider, MD, Dieter Horstkotte, MD, PhD, FESC, FACC, Christian W. Hamm, MD, FESC^_* and Heinz-Friedrich Pitschner, MD, FESC^_*

^_* Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany
Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Department of Cardiology, Center of Cardiovascular Medicine, Bad Neustadt/Saale, Germany.

Manuscript received January 15, 2008; revised manuscript received March 12, 2008, accepted April 3, 2008.

^_* Reprint requests and correspondence: Dr. Thomas Neumann, Department of Cardiology, Kerckhoff Heart Center, Benekestr. 2-8, 61231 Bad Nauheim, Germany. (Email: t.neumann{at}kerckhoff-klinik.de).

Objectives: The purpose of this study was to investigate the efficacy safety of the novel cryoballoon device (Arctic Front, Cryocath, Quebec, Canada).

Background: Antral pulmonary vein (PV) ablation with radiofrequency energy is widely used as a strategy for catheter ablation of paroxysmal atrial fibrillation (PAF). A novel double lumen cryoballoon catheter was designed for circumferential pulmonary vein isolation (PVI) with the cryoablation technique.

Methods: We consecutively enrolled 346 patients with symptomatic, drug refractory paroxysmal (n = 293) or persistent (n = 53) atrial fibrillation (AF). In all patients, PVI of all targeted PVs was the therapeutic aim. The primary end points of this nonrandomized study were: 1) acute isolation rate of targeted PV; and 2) first electrocardiogram-documented recurrence of AF. The secondary end point was occurrence of PV stenosis or atrio-esophageal fistula.

Results: The 1,360 of 1,403 PVs (97%) were targeted with balloons or balloons in combination with the use of Freezor Max (Cryocath). We found that ablation with the cryoballoon resulted in maintenance of sinus rhythm in 74% of patients with PAF and 42% of patients with persistent AF. No PV narrowing occurred. The most frequent complication was right phrenic nerve palsy observed during cryoballoon ablation at the right superior PV.

Conclusions: Pulmonary vein isolation with a new cryoballoon technique is feasible. Sinus rhythm can be maintained in the majority of patients with PAF by circumferential PVI using a cryoballoon ablation system. Cryoablation was less effective in patients with persistent AF than in patients with PAF.

Key Words: ablation • arrhythmia • cryoballoon • catheter ablation • tachyarrhythmias • atrial fibrillation • pulmonary veins

Abbreviations and Acronyms   AF = atrial fibrillation   LA = left atrium/atrial   MRI = magnetic resonance imaging   PAF = paroxysmal atrial fibrillation   PNP = phrenic nerve palsy   PV = pulmonary vein   PVI = pulmonary vein isolation

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A23-A24. [Full Text] [PDF]

This article has been cited by other articles:

				Y. Van Belle, P. Janse, D. Theuns, T. Szili-Torok, and L. Jordaens One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation Europace, November 1, 2008; 10(11): 1271 - 1276. [Abstract] [Full Text] [PDF]

				R. Weerasooriya, P. Jais, M. Hocini, F. Sacher, and M. Haissaguerre Balloon cryoablation for paroxysmal atrial fibrillation Europace, November 1, 2008; 10(11): 1251 - 1252. [Full Text] [PDF]